Norwalk Hospital

Summary

Norwalk Hospital is a medical facility located in Norwalk, Connecticut. This center is recognized for care of Breast Cancer, Breast cancer, Ovarian Cancer, Cancer, Pancreatic Cancer and other specialties. Norwalk Hospital is involved with conducting 92 clinical trials across 125 conditions. There are 4 research doctors associated with this hospital, such as Richard Frank, MD, Linus Chuang, MD, Philip Gilbo, MD, and Lisa Phuong.

Top PIs

Clinical Trials running at Norwalk Hospital

Breast Cancer

Ovarian Cancer

Breast cancer

Pancreatic Cancer

Cervical Cancer

Cancer

Lung Cancer

Uterine Cancer

Ductal Carcinoma In Situ

Endometrial Adenocarcinoma

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.

Recruiting

2 awards

Phase 3

19 criteria

Low Dose Tamoxifen

for Breast Cancer

This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.

Recruiting

2 awards

Phase 3

8 criteria

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.

Recruiting

2 awards

Phase 3

19 criteria